Investor Relations
Cancer Genetics, Inc (CGI) is a privately held company based in Rutherford, NJ with offices in Milan, Italy. CGI has a synergistic business model compromised of a clinical reference laboratory focused on state-of-the-art oncology testing, which is CLIA and CAP accredited, and a division that develops molecular diagnostic products for hematological malignancies, urogenital cancers, and HPV-associated cancers. Major shareholders include the founders of CGI, Equity Dynamics and Pappajohn Capital. For additional information please contact us at ir@cancergenetics.com.
Financing Milestones
November 2010
CGI closes a Series B financing round raising $10 million.
November 2007
CGI closes Series A financing round raising $5 million.
Shareholder Updates
CGI periodically sends out updates regarding the business and other operational milestones. To be added to the list, or to request prior shareholder letters, please contact ir@cancergenetics.com.
